0001140361-12-015190.txt : 20120313 0001140361-12-015190.hdr.sgml : 20120313 20120313155532 ACCESSION NUMBER: 0001140361-12-015190 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120307 FILED AS OF DATE: 20120313 DATE AS OF CHANGE: 20120313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wilson Kenneth W. CENTRAL INDEX KEY: 0001530777 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 12687139 MAIL ADDRESS: STREET 1: C/O HANGER ORTHOPEDIC GROUP, INC. STREET 2: 10910 DOMAIN DRIVE, SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 512-777-3800 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 doc1.xml FORM 4 X0304 4 2012-03-07 0 0000722723 HANGER ORTHOPEDIC GROUP INC HGR 0001530777 Wilson Kenneth W. C/O HANGER ORTHOPEDIC GROUP, INC. 10910 DOMAIN DRIVE, SUITE 300 AUSTIN TX 78758 0 1 0 0 Pres./COO Southern Prosthetic* Common Stock 2012-03-07 4 A 0 3000 0 A 18000 D The restricted stock being reported does not include the contingent right of the reporting person to receive up to 9,000 additional performance shares under the issuer's 2010 Omnibus Incentive Plan based on the achievement of certain performance targets for the fiscal year 2012. Includes (i) unvested restricted shares which total 3,000 shares of stock from an initial grant of 3,000 shares of restricted stock made on March 7, 2012; and (ii) unvested restricted shares which total 15,000 shares of stock from an initial grant of 15,000 shares of restricted stock made on September 19, 2011. All remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. * President and Chief Operating Officer of Southern Prosthetic Supply, Inc. Jessica Lochmann Allen, Attorney-in-Fact for Kenneth W. Wilson 2012-03-13